Kiniksa Pharmaceuticals International PLC (KNSA)
22.03
+0.55
(+2.56%)
USD |
NASDAQ |
Nov 05, 16:00
22.03
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Total Assets (Quarterly): 555.30M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 555.30M |
| June 30, 2024 | 542.43M |
| March 31, 2024 | 519.67M |
| December 31, 2023 | 526.32M |
| September 30, 2023 | 483.06M |
| June 30, 2023 | 484.33M |
| March 31, 2023 | 442.86M |
| December 31, 2022 | 459.67M |
| September 30, 2022 | 459.95M |
| June 30, 2022 | 210.58M |
| March 31, 2022 | 230.96M |
| December 31, 2021 | 232.80M |
| September 30, 2021 | 252.86M |
| June 30, 2021 | 279.21M |
| Date | Value |
|---|---|
| March 31, 2021 | 311.16M |
| December 31, 2020 | 349.46M |
| September 30, 2020 | 384.41M |
| June 30, 2020 | 271.44M |
| March 31, 2020 | 226.11M |
| December 31, 2019 | 254.53M |
| September 30, 2019 | 281.80M |
| June 30, 2019 | 308.14M |
| March 31, 2019 | 346.16M |
| December 31, 2018 | 321.96M |
| September 30, 2018 | 347.10M |
| June 30, 2018 | 365.13M |
| March 31, 2018 | 224.78M |
| December 31, 2017 | 47.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
210.58M
Minimum
Jun 2022
555.30M
Maximum
Sep 2024
373.86M
Average
366.94M
Median
Total Assets (Quarterly) Benchmarks
| OPKO Health Inc | 1.980B |
| Ligand Pharmaceuticals Inc | 866.40M |
| Organon & Co | 12.75B |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 118.29M |
| Shareholders Equity (Quarterly) | 437.01M |
| Current Ratio | 3.244 |